{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:28:40Z","timestamp":1787725720329,"version":"build-2784847793"},"reference-count":57,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Graduate Student Scientific Research and Practice Innovation Projects","award":["KYCX23_1933"],"award-info":[{"award-number":["KYCX23_1933"]}]},{"name":"Graduate Student Scientific Research and Practice Innovation Projects","award":["SJCX23_0662"],"award-info":[{"award-number":["SJCX23_0662"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272863"],"award-info":[{"award-number":["82272863"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,9,14]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metastatic recurrence poses a significant challenge in cancer treatment, impacting patient survival and prognosis. Understanding the biological mechanisms behind it is essential for improving treatment strategies and patient outcomes. Lung cancer, the leading cause of cancer-related deaths, is a focus of research for treatment and prognosis. This study specifically targets stage III non-small cell lung cancer (NSCLC) patients following surgery due to their high recurrence variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To delve into the mechanisms of metastatic recurrence in stage III NSCLC patients, we used a comprehensive experimental approach. Long-term follow-up of postoperative patients was combined with single-cell sequencing to uncover tumor microenvironment changes. In vivo and in vitro experiments, including tissue cytometry analysis, real-time PCR, western blotting, gene silencing, cell co-culture, flow cytometry, and chromatin immunoprecipitation-quantitative PCR, were conducted to investigate ALCAM-related gene regulation. Tissue samples and clinical data were collected from stage III NSCLC patients who underwent lung cancer resection between August 2018 and July 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Analysis revealed distinct epithelial gene expression patterns between recurrence and non-recurrence groups, highlighting the reduced interaction between ALCAM ligand on epithelial cells and CD6 receptor on T cells. Lower ALCAM levels intensified an immunosuppressive state, halting cell cycle progression and promoting tumor proliferation and migration, linked to metastatic recurrence. The transcription factor MYB was identified as a key ALCAM regulator, shedding light on its impact on tumor advancement. Reduced ALCAM expression correlated with poorer prognosis, offering insights into NSCLC recurrence mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study underscores the pivotal role of the ALCAM-CD6 axis in metastatic recurrence of stage III NSCLC. ALCAM regulation not only influences immune-tumor cell interactions but also drives tumor cell proliferation and migration by affecting the cell cycle. This finding presents a promising target for NSCLC treatment and aids in assessing patient prognosis effectively.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2024-010416","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:50:55Z","timestamp":1760093455000},"page":"e010416","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["ALCAM-CD6 axis suppression: a key determinant of immune-mediated metastasis recurrence in stage III non-small cell lung cancer"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7951-0123","authenticated-orcid":false,"given":"Shaodi","family":"Wen","sequence":"first","affiliation":[{"name":"Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaolin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"Department of Anesthesiology, Shantou Central Hospital, Shantou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6569-5956","authenticated-orcid":false,"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8084-2800","authenticated-orcid":false,"given":"Guoren","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5237-1992","authenticated-orcid":false,"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchuang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9708-6098","authenticated-orcid":false,"given":"Bo","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"2025111301352291000_13.10.e010416.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2025111301352291000_13.10.e010416.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.010"},{"key":"2025111301352291000_13.10.e010416.3","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0010"},{"key":"2025111301352291000_13.10.e010416.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2019.03.026"},{"key":"2025111301352291000_13.10.e010416.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0038-z"},{"key":"2025111301352291000_13.10.e010416.6","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2002.18607.x"},{"key":"2025111301352291000_13.10.e010416.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3881"},{"key":"2025111301352291000_13.10.e010416.8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011272200"},{"key":"2025111301352291000_13.10.e010416.9","doi-asserted-by":"publisher","DOI":"10.1078\/0171-9335-00256"},{"key":"2025111301352291000_13.10.e010416.10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12964-024-01658-y","article-title":"The CD6 interactome orchestrates ligand-independent T cell inhibitory signaling","volume":"22","author":"Santos","year":"2024","journal-title":"Cell Commun Signal"},{"key":"2025111301352291000_13.10.e010416.11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011700"},{"key":"2025111301352291000_13.10.e010416.12","doi-asserted-by":"crossref","unstructured":"Hansen AG , Swart GW , Zijlstra A . ALCAM: Basis Sequence: Mouse. AFCS Nat Mol Pages 2011;2011. doi:10.1038\/mp.a004126.01","DOI":"10.1038\/mp.a004126.01"},{"key":"2025111301352291000_13.10.e010416.13","first-page":"231","article-title":"ALCAM\/CD166: cancer-related issues","volume":"7","author":"Weidle","year":"2010","journal-title":"Cancer Genomics Proteomics"},{"key":"2025111301352291000_13.10.e010416.14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2193"},{"key":"2025111301352291000_13.10.e010416.15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145662","article-title":"CD6 is a target for cancer immunotherapy","volume":"6","author":"Ruth","year":"2021","journal-title":"JCI Insight"},{"key":"2025111301352291000_13.10.e010416.16","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa028"},{"key":"2025111301352291000_13.10.e010416.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.04.044"},{"key":"2025111301352291000_13.10.e010416.18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049"},{"key":"2025111301352291000_13.10.e010416.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.07.011"},{"key":"2025111301352291000_13.10.e010416.20","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4096"},{"key":"2025111301352291000_13.10.e010416.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0"},{"key":"2025111301352291000_13.10.e010416.22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16164-1","article-title":"Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"2025111301352291000_13.10.e010416.23","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4463"},{"key":"2025111301352291000_13.10.e010416.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9"},{"key":"2025111301352291000_13.10.e010416.25","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"2025111301352291000_13.10.e010416.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0068-4"},{"key":"2025111301352291000_13.10.e010416.27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.4325"},{"key":"2025111301352291000_13.10.e010416.28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0196"},{"key":"2025111301352291000_13.10.e010416.29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1403"},{"key":"2025111301352291000_13.10.e010416.30","doi-asserted-by":"publisher","DOI":"10.1097\/01.JTO.0000445598.81357.ff"},{"key":"2025111301352291000_13.10.e010416.31","doi-asserted-by":"crossref","first-page":"100958","DOI":"10.1016\/j.xinn.2025.100958","article-title":"aplot: Simplifying the creation of complex graphs to visualize associations across diverse data types","volume":"6","author":"Xu","year":"2025","journal-title":"The Innovation"},{"key":"2025111301352291000_13.10.e010416.32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1066"},{"key":"2025111301352291000_13.10.e010416.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-023-00618-5"},{"key":"2025111301352291000_13.10.e010416.34","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31826bfbc6"},{"key":"2025111301352291000_13.10.e010416.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30924-1"},{"key":"2025111301352291000_13.10.e010416.36","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04571-9","article-title":"Suppression of histone deacetylase 1 by JSL-1 attenuates the progression and metastasis of cholangiocarcinoma via the TPX2\/Snail axis","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis"},{"key":"2025111301352291000_13.10.e010416.37","doi-asserted-by":"crossref","first-page":"618540","DOI":"10.3389\/fonc.2021.618540","article-title":"TPX2 Enhanced the Activation of the HGF\/ETS-1 Pathway and Increased the Invasion of Endocrine-Independent Prostate Carcinoma Cells","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"2025111301352291000_13.10.e010416.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01290-2","article-title":"Therapeutic targeting of the TPX2\/TTK network in colorectal cancer","volume":"21","author":"Shaath","year":"2023","journal-title":"Cell Commun Signal"},{"key":"2025111301352291000_13.10.e010416.39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065607","article-title":"Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome","volume":"24","author":"Trujillo-Paolillo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025111301352291000_13.10.e010416.40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ijc.32981","article-title":"Development and validation of a five-gene model to predict postoperative brain metastasis in operable lung adenocarcinoma","volume":"147","author":"Fu","year":"2020","journal-title":"Int J Cancer"},{"key":"2025111301352291000_13.10.e010416.41","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/stem.1665","article-title":"Activated leukocyte cell adhesion molecule (CD166): an \u201cinert\u201d cancer stem cell marker for non-small cell lung cancer?","volume":"32","author":"Tachezy","year":"2014","journal-title":"Stem Cells"},{"key":"2025111301352291000_13.10.e010416.42","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-9-266","article-title":"Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer","volume":"9","author":"King","year":"2010","journal-title":"Mol Cancer"},{"key":"2025111301352291000_13.10.e010416.43","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2367843","article-title":"ALCAM-mediated cDC1 CD8 T cells interactions are suppressed in advanced lung tumors","volume":"13","author":"Morosi","year":"2024","journal-title":"Oncoimmunology"},{"key":"2025111301352291000_13.10.e010416.44","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02631-2","article-title":"NAD pool as an antitumor target against cancer stem cells in head and neck cancer","volume":"42","author":"Navas","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"2025111301352291000_13.10.e010416.45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010876","article-title":"Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential \u201cSeed\u201d and \u201cSoil\u201d Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025111301352291000_13.10.e010416.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2021.07.001"},{"key":"2025111301352291000_13.10.e010416.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0361-z"},{"key":"2025111301352291000_13.10.e010416.48","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-019-09957-2"},{"key":"2025111301352291000_13.10.e010416.49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1615253114"},{"key":"2025111301352291000_13.10.e010416.50","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.119"},{"key":"2025111301352291000_13.10.e010416.51","doi-asserted-by":"publisher","DOI":"10.1093\/stcltm\/szad012"},{"key":"2025111301352291000_13.10.e010416.52","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1026521","article-title":"The dual role of CD6 as a therapeutic target in cancer and autoimmune disease","volume":"9","author":"Gurrea-Rubio","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025111301352291000_13.10.e010416.53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006706","article-title":"Modeling cell line-specific recruitment of signaling proteins to the insulin-like growth factor 1 receptor","volume":"15","author":"Erickson","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"2025111301352291000_13.10.e010416.54","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E19-09-0548"},{"key":"2025111301352291000_13.10.e010416.55","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01444-x"},{"key":"2025111301352291000_13.10.e010416.56","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071841","article-title":"Optimization and Characterization of Novel ALCAM-Targeting Antibody Fragments for Transepithelial Delivery","volume":"15","author":"Bauer","year":"2023","journal-title":"Pharmaceutics"},{"key":"2025111301352291000_13.10.e010416.57","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-023-03578-1","article-title":"Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells","volume":"73","author":"Gurrea-Rubio","year":"2024","journal-title":"Cancer Immunol Immunother"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2024-010416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:35:49Z","timestamp":1763026549000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2024-010416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,10]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/jitc-2024-010416"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2024-010416","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}